MedPath

PFIZER INC.

PFIZER INC. logo
🇺🇸United States
Ownership
Public
Established
1849-01-01
Employees
88K
Market Cap
$163.3B
Website
http://www.pfizer.com

Study Examing The Effect of Grapefruit Juice On The Blood And Urine Samples of Study Drug And Its By Product And Safety

Phase 1
Completed
Conditions
Obesity
Interventions
First Posted Date
2008-03-27
Last Posted Date
2009-08-10
Lead Sponsor
Pfizer
Target Recruit Count
28
Registration Number
NCT00645216
Locations
🇺🇸

Pfizer Investigational Site, New Haven, Connecticut, United States

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Acute Symptoms of Chronic Bronchitis

Phase 3
Completed
Conditions
Bronchitis, Chronic
Interventions
Other: placebo
First Posted Date
2008-03-26
Last Posted Date
2011-05-16
Lead Sponsor
Pfizer
Target Recruit Count
551
Registration Number
NCT00644449
Locations
🇻🇪

Pfizer Investigational Site, Caracas, Venezuela

A Multicenter, Randomized, Double-Blind, Double-Dummy Comparative Trial of Azithromycin Sustained Release Versus 3-Day Azithromycin for the Treatment of Strep Throat in Adolescents and Adults

Phase 3
Completed
Conditions
Pharyngitis
Tonsillitis
Interventions
First Posted Date
2008-03-26
Last Posted Date
2011-06-08
Lead Sponsor
Pfizer
Target Recruit Count
598
Registration Number
NCT00644293
Locations
🇬🇧

Pfizer Investigational Site, Kent, United Kingdom

A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures

Phase 3
Completed
Conditions
Sleep Deprivation
Epilepsies, Partial
Interventions
Drug: Placebo
First Posted Date
2008-03-26
Last Posted Date
2008-04-24
Lead Sponsor
Pfizer
Target Recruit Count
17
Registration Number
NCT00643136
Locations
🇳🇱

Pfizer Investigational Site, Heeze, Netherlands

Multicenter, Open, Randomized Comparative Trial To Compare The Efficacy Of Azithromycin Versus Amoxicillin In Children With Strep Throat

Phase 4
Completed
Conditions
Tonsillitis
Interventions
Drug: Clamoxyl
First Posted Date
2008-03-26
Last Posted Date
2008-03-26
Lead Sponsor
Pfizer
Target Recruit Count
360
Registration Number
NCT00643539
Locations
🇫🇷

Pfizer Investigational Site, Versailles, France

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Clarithromycin Extended Release for the Treatment of Pneumonia in Adult Patients

Phase 3
Completed
Conditions
Pneumonia
Interventions
First Posted Date
2008-03-26
Last Posted Date
2008-03-26
Lead Sponsor
Pfizer
Target Recruit Count
504
Registration Number
NCT00643227
Locations

Pfizer Investigational Site

A Multicenter, Randomized, Double-Blind, Double-Dummy Trial of Azithromycin SR Compared With Levofloxacin for the Treatment of Mild to Moderate Pneumonia in Adult Patients

Phase 3
Completed
Conditions
Pneumonia
Interventions
First Posted Date
2008-03-26
Last Posted Date
2008-03-26
Lead Sponsor
Pfizer
Target Recruit Count
468
Registration Number
NCT00643734
Locations
🇷🇺

Pfizer Investigational Site, Smolensk, Russian Federation

A Randomized, Open Label, Clinical Trial of the Pharmacokinetics of Azithromycin Following a Single Dose of Azithromycin Sustained Release (2 Gram) or Commercial Azithromycin Tablet (500 mg) to Cancer Patients That Require Lung Surgery

Phase 2
Completed
Conditions
Pharmacokinetics
Interventions
First Posted Date
2008-03-26
Last Posted Date
2011-06-08
Lead Sponsor
Pfizer
Target Recruit Count
66
Registration Number
NCT00644176
Locations
🇮🇹

Pfizer Investigational Site, Pisa, Italy

A Single, High-Dose Azithromycin Extended Release (60 mg/kg) Compared With 10 Days of High-Dose Amoxicillin Clavulanate in Children With Ear Infections at High Risk of Persistent/Recurrent Ear Infections

Phase 3
Completed
Conditions
Acute Otitis Media
Interventions
Drug: amoxicillin/clavulanate postassium (Augmentin ES-600)
First Posted Date
2008-03-26
Last Posted Date
2011-05-17
Lead Sponsor
Pfizer
Target Recruit Count
902
Registration Number
NCT00643292
Locations

Pfizer Investigational Site

A Multicenter, Randomized, Double-Blind, Double-Dummy Study Of Azithromycin SR Versus Amoxicillin For The Treatment Of Strep Throat In Children

Phase 3
Completed
Conditions
Tonsillitis
Interventions
First Posted Date
2008-03-26
Last Posted Date
2011-05-17
Lead Sponsor
Pfizer
Target Recruit Count
693
Registration Number
NCT00643149
Locations
🇮🇳

Pfizer Investigational Site, Mumbai, Maharashtra, India

© Copyright 2025. All Rights Reserved by MedPath